Arvinas, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New Haven, CT
ARVN chart
What traders are saying about $ARVN
Latest postsArvinas, Inc. news
- Arvinas, Inc. (ARVN) stock price, news, quote and history
Yahoo Finance UK ·
- Arvinas, Inc. (ARVN) Seasonal returns chart
Yahoo Finance UK ·
- Rigel Pharmaceuticals Inc (RIGL) (Q3 2026) Earnings Call Highlights: Record Product Sales of ...
Yahoo Finance ·
- Arvinas falls 2.14% in Friday's session
Global Banking & Finance Review ·
- Growth Investors: Industry Analysts Just Upgraded Their Arvinas, Inc. (NASDAQ:ARVN) Revenue Forecasts By 16%
Simply Wall St ·
- FY2026 Earnings Forecast for Arvinas Issued By HC Wainwright
MarketBeat ·
- Arvinas to present ARV-393 lymphoma trial data at ASH meeting
Investing.com ·
- Arvinas to Present Preliminary Clinical Data from Early Monotherapy Dose Escalation Cohorts in the Phase 1 Trial for ARV-393 (Zaloblideg), a PROTAC BCL6 Degrader, at the 2026 American Society of Hematology (ASH®) Annual Meeting
Yahoo Finance ·
- H.C. Wainwright cuts Arvinas stock price target to $13 from $18
Investing.com ·
- What Arvinas Bears Saw Before The Fall
Yahoo Finance ·
- H.C. Wainwright cuts Arvinas stock price target to $13 from $18 By Investing.com
Investing.com South Africa ·
- Surprised By Arvinas’ Slide? What Bears Saw
Simply Wall St ·
Arvinas, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $262.6M | $263.4M | $78.5M | $131.4M |
| Net income | -$81.0M | -$199.0M | -$367.0M | -$283.0M |
| Diluted EPS | $-1.14 | $-2.77 | $-6.62 | $-5.31 |
| Total assets (year end) | $717.9M | $1.09B | $1.30B | $1.27B |
| Cash and equivalents (year end) | $142.9M | $100.5M | $311.7M | $81.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arvinas, Inc.
- Ticker
- ARVN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, CT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1655759
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
Frequently asked questions
What exchange is Arvinas, Inc. listed on?
Arvinas, Inc. trades on the Nasdaq under the ticker symbol ARVN.
What industry is Arvinas, Inc. in?
Arvinas, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arvinas, Inc. headquartered?
Arvinas, Inc.'s business address on file with the SEC is in New Haven, CT.
When does Arvinas, Inc.'s fiscal year end?
Arvinas, Inc.'s fiscal year ends on December 31.
How much revenue did Arvinas, Inc. report?
Arvinas, Inc. reported $262.6M in revenue for calendar year 2025, according to its SEC filings.